CINA-LVO
AI-Powered Large Vessel Occlusion Detection on CT
Large vessel occlusion is responsible for the most severe ischemic strokes. CINA-LVO analyzes brain CT angiography scans automatically and delivers results to your radiologist's worklist within few seconds.
CE-marked
MDR IIb
FDA-cleared
Class II
Anterior Circulation Coverage.
Large vessel occlusion is not a single presentation. It spans a spectrum of vessel segments, each carrying a different level of clinical visibility, and a different risk of being missed.
Proximal Occlusion
ICA terminus and MCA M1 occlusions are the most severe presentations of ischemic stroke. When a radiologist identifies one, it triggers an immediate cascade: stroke team activation, angiography suite preparation, thrombectomy team on standby. The call is high-stakes, and it has to be fast.CINA-LVO provides a first-pass analysis before the radiologist opens the scan, so confirmation, not detection, becomes the task.
Distal Occlusion
MCA M2 occlusions are smaller, subtler, and significantly harder to see on CTA. Vessel tortuosity, contrast timing variability, and reading fatigue all raise the risk of a missed finding. Yet M2 occlusions cause real disability, and they are increasingly eligible for mechanical thrombectomy.CINA-LVO is specifically validated on M2, covering the vessel segment where the diagnostic challenge is greatest.
Every CT angiography scan is analyzed automatically, from ICA to MCA, regardless of the time of day, the scan volume, or the complexity of the presentation. The radiologist receives an alert before reviewing the case.
Large Vessel Occlusion Detection
Triage tool for CT angiography detecting large vessel occlusions across the anterior circulation in acute ischemic stroke.
Detection Coverage
- Alert delivered to the radiologist's worklist before the scan is opened
- Vessel segment identified in the alert, not just occlusion presence
- M2 detection validated in a dedicated peer-reviewed study
Triage tool for CT angiography detecting large vessel occlusions across the anterior circulation in acute ischemic stroke.
Detection Coverage
Clinical Evidence
2021
Mc Louth et Al.
Frontiers
Validated study across 378 CT angiography scans in an US multicenter, establishing CINA-LVO as a reliable triage tool for acute ischemic stroke across a diverse clinical population.
2023
Temmen et al
Scientific Reports
In a real-world emergency stroke workflow, AI-supported LVO detection reduced average radiologist reading time, a 6.5x acceleration, without loss of diagnostic accuracy.
2025
Franciosini et al.
Stroke Journal
In a study of 557 patients specifically including MCA M2 occlusions, confirming CINA-LVO detection accuracy in the vessel segment most often missed on standard CTA review.
A Radiologist's Perspective
“When dealing with a stroke, time is of the essence, and being able to prioritize effectively is critical to saving lives and improving outcomes. Not only does CINA help radiologists to identify pathologies quickly, but also to highlight those that require the most urgent care.”
Peter chang
Radiologist, UC Irvine School of Medicine (USA)
Frequently Asked Questions
CINA-LVO detects large vessel occlusions across the anterior circulation: distal Internal Carotid Artery, the middle cerebral artery M1 segment, and the MCA M2 segment.
CINA-LVO has been validated across multicentre, multivendor cohorts, including scans acquired under varying contrast timing conditions and kilovoltage settings. The algorithm is designed for real-world variability, not just ideal acquisitions. False positives attributable to timing artefacts are addressed through the radiologist’s confirmatory review, which remains the final step before any clinical action.
CINA-LVO connects to your PACS via standard DICOM. When a brain CTA is acquired, the analysis runs automatically, with no manual trigger and no separate application. The result appears directly in the radiologist’s worklist as an additional overlay image, with a flag if an occlusion is detected. The radiologist confirms or rules out the finding before any clinical decision is made. No extra login, no workflow change.
CINA-LVO, medical images analysis software, a medical device manufactured by Avicenna.AI. This medical device is reserved for health professionals. The performance and outputs of this tool may differ slightly according to the software version and applicable regulations.
This software has been designed and manufactured according to the EN ISO 13485 Quality management system. Read the instructions in the notice carefully before any use.
- Instructions for Use are available.
- Manufacturer: Avicenna.AI (France).
- Medical device Class IIb following the European Regulation on Medical Device (EU) 2017/745.
- Medical device Class II following the Code of Federal Regulations of the United States of America 21CFR on Medical Devices.
Download OUR CASE STUDY
Complete the form below to access the CINA-LVO case study.
Related AI Solutions
Complete your AI portfolio.